ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: Charlotte

Alcohoot combats drunk driving with enforcement grade smartphone breathalyzer

Alcohoot combats drunk driving with enforcement grade smartphone breathalyzer

April 26, 2013 12:51 pm by | 0 Comments

Drunk driving is bad. It just is. On a mission to fight this problem, Alcohoot has created ’the world’s first enforcement grade smartphone breathalyzer’. Alcohoot is a device that plugs ... Read more
As health system drops “cheat death” tagline, it acknowledges marketing milestone

As health system drops “cheat death” tagline, it acknowledges marketing milestone

April 8, 2013 6:34 pm by | 0 Comments

It’s not often you hear about a health system that wants to position the word “death” by its name. After less than a week a North Carolina hospital system has ... Read more
Healthcare idea hub collaborating with public hospital group seeks entrepreneurs

Healthcare idea hub collaborating with public hospital group seeks entrepreneurs

July 18, 2012 2:00 pm by | 0 Comments

A product development business has made a big move into healthcare, collaborating with the second-largest public hospital group in the country to launch a healthcare and medical device innovation business. ... Read more
CHTP cuts executive pay 25 percent, suspends bonuses to pay for trials

CHTP cuts executive pay 25 percent, suspends bonuses to pay for trials

June 7, 2012 5:47 pm by | 0 Comments

Drug developers typically turn to investors to finance clinical work on drug candidates. Chelsea Therapeutics (NASDAQ:CHTP) executives and directors are slashing their own paychecks to help pay for that work ... Read more
CRO Inclinix merges with clinical trials site operator PMG Research

CRO Inclinix merges with clinical trials site operator PMG Research

June 4, 2012 5:15 pm by | 0 Comments

Clinical research organization Inclinix is merging with PMG Research in the latest merger and acquisition deal to hit the CRO space.Inclinix provides clinical trial recruitment services for pharmaceutical, biotechnology and ... Read more
CHTP’s arthritis drug fails phase 2; now everything rides on Northera

CHTP’s arthritis drug fails phase 2; now everything rides on Northera

May 31, 2012 11:00 am by | 1 Comments

Chelsea Therapeutics‘ (NASDAQ:CHTP) rheumatoid arthritis treatment failed in phase 2 clinical trials and leaves the beleaguered drug developer to focus its remaining resources on an orphan drug candidate that has ... Read more
Chelsea Therapeutics to modify Northera study, resubmit NDA in 2013

Chelsea Therapeutics to modify Northera study, resubmit NDA in 2013

May 22, 2012 10:59 am by | 0 Comments

Chelsea Therapeutics (NASDAQ:CHTP), regrouping from orphan drug Northera’s failure to secure regulatory approval, now plans to resubmit a new drug application in early 2013 with data from a modified phase ... Read more
CHTP might seek limited Northera approval, meets with FDA this month

CHTP might seek limited Northera approval, meets with FDA this month

May 2, 2012 2:15 pm by | 0 Comments

Chelsea Therapeutics (NASDAQ:CHTP) won’t meet with regulators until later this month to discuss its orphan drug Northera but the company is already staking out scenarios of a more limited approval ... Read more
CHTP’s Northera rejected; FDA seeks more data for the orphan drug

CHTP’s Northera rejected; FDA seeks more data for the orphan drug

March 28, 2012 7:41 pm by | 0 Comments

Chelsea Therapeutics‘s (NASDAQ:CHTP) drug candidate Northera failed in its bid to secure U.S. Food and Drug Administration approval.But a door to approval remains cracked open for the company. The FDA’s ... Read more
CHTP’s Northera expected to get FDA approval decision today

CHTP’s Northera expected to get FDA approval decision today

March 28, 2012 7:00 am by | 1 Comments

Northera, the Chelsea Therapeutics (NASDAQ:CHTP) compound developed to treat dizziness and fainting in Parkinson’s disease patients, could get word from regulators today on marketing approval.The Prescription Drug User Fee Act ... Read more
FDA panel recommends approval for Chelsea Therapeutics’ Northera

FDA panel recommends approval for Chelsea Therapeutics’ Northera

February 23, 2012 5:10 pm by | 1 Comments

Updated 7:29 p.m.Northera, the Chelsea Therapeutics (NASDAQ:CHTP) drug developed to treat dizziness and fainting experienced by Parkinson’s disease patients, has the nod for approval from an advisory committee to the ... Read more
FDA review recommends no approval for CHTP’s Northera

FDA review recommends no approval for CHTP’s Northera

February 21, 2012 1:16 pm by | 4 Comments

Chelsea Therapeutics (NASDAQ:CHTP) CEO Simon Pedder’s recent defense of drug candidate Northera omitted a key detail: The U.S. Food and Drug Administration reviewer for Northera recommended the agency not approve ... Read more
FDA raises safety concerns on Chelsea’s Northera for Parkinson’s patients

FDA raises safety concerns on Chelsea’s Northera for Parkinson’s patients

February 13, 2012 3:47 pm by | 0 Comments

Chelsea Therapeutics (NASDAQ:CHTP) won’t meet with a U.S. Food and Drug Administration advisory committee to discuss drug candidate Northera for another 10 days, but CEO Simon Pedder used a biosciences ... Read more
CHTP submits $100M shelf filing ahead of FDA decision on Northera

CHTP submits $100M shelf filing ahead of FDA decision on Northera

February 2, 2012 5:08 pm by | 0 Comments

Drug developer Chelsea Therapeutics (NASDAQ:CHTP) is expanding its financial cushion to the tune of $100 million in advance of a regulatory decision on what could be the company’s first approved ... Read more
Stock offering nets $22.1M for drug developer Chelsea Therapeutics

Stock offering nets $22.1M for drug developer Chelsea Therapeutics

January 12, 2012 10:47 am by | 0 Comments

The stock offering that Chelsea Therapeutics (NASDAQ:CHTP) expected to bring in $19.2 million in fresh capital has raised even more money with the sale of additional shares.Chelsea net $22.1 million ... Read more